Managing Failure to Antiretroviral Drugs in HIV-1-Infected Patients
Nicola Gianotti, Adriano Lazzarin
Abstract
Nicola Gianotti, Adriano Lazzarin
Abstract
Managing failure to antiretroviral therapies implies the addressing of several issues: the clinical stage, the virological and the immunological response to the failing regimen, together with drug history, resistance and exposure. Each of these issues will be discussed with the aim of providing useful data to design an optimal rescue antiretroviral therapy.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Managing failure to antiretroviral therapies implies the addressing of several issues: the clinical stage, the virological and the immunological response to the failing regimen, together with drug history, resistance and exposure. Each of these issues will be discussed with the aim of providing useful data to design an optimal rescue antiretroviral therapy.
Key concepts: Human immunodeficiency virus (HIV), Medicine, Antiretroviral therapy, ANTIRETROVIRAL AGENTS, Antiretroviral drug, Intensive care medicine, Virology, Pharmacology